Individualised proteome profiling of human endometrial tumours improves detection of new prognostic markers
Open Access
- 9 July 2013
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 109 (3) , 704-713
Abstract
The individual features of tumours are often disregarded in cohort studies. As these features may represent a source for individualised cancer treatment, it is important to develop a novel approach for their assessment. We used proteomics, systems biology, and immunohistochemistry to explore protein expression in human endometrial tumours, to identify deregulated regulatory mechanisms, and to validate observed changes in protein expression using tissue microarrays. Compared with the evaluation of common tumour features, the evaluation of individual tumour features gave a more comprehensive and detailed overview of the regulatory processes in endometrial tumours. Systemic analysis of the individual proteome profiles showed that endometrial tumours employed different proteins to regulate similar functions. Comparison of our data with publicly available data sets of molecular profiling of human endometrial tumours confirmed that individual tumour features are not simply irrelevant individual variations, but are indeed important in endometrial tumorigenesis. Validation through tissue microarray investigation of MST1 and PKN1 proteins confirmed the usefulness of this approach, and suggested that MST1 and PKN1 may be considered as predictive biomarkers of endometrial cancer. We show that individualised profiling of endometrial tumours may deliver better insights into a tumour’s physiology, thereby giving a better prediction of tumour development. Individual tumour features may also be used to tailor cancer treatment.Keywords
This publication has 35 references indexed in Scilit:
- Full‐length Mst1 exhibits growth promoting function in human hepatocellular carcinoma cellsFEBS Letters, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectivesEMBO Molecular Medicine, 2012
- Personalized therapy in endometrial cancer: Challenges and opportunitiesCancer Biology & Therapy, 2012
- Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicineJournal of Internal Medicine, 2011
- Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometriumAnnals of Oncology, 2011
- PRK1 distribution in normal tissues and carcinomas: overexpression and activation in ovarian serous carcinomaHuman Pathology, 2009
- Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activationProceedings of the National Academy of Sciences, 2009
- Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancerLaboratory Investigation, 2007
- The systems biology markup language (SBML): a medium for representation and exchange of biochemical network modelsBioinformatics, 2003